[HTML][HTML] Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
SJM Hahné, IK Veldhuijzen, L Wiessing, TA Lim… - BMC infectious …, 2013 - Springer
Background Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV)
infection is improving but not benefiting individuals unaware to be infected. To inform …
infection is improving but not benefiting individuals unaware to be infected. To inform …
[PDF][PDF] Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
SJM Hahné, IK Veldhuijzen, L Wiessing, TA Lim… - 2013 - cyberleninka.org
Background: Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV)
infection is improving but not benefiting individuals unaware to be infected. To inform …
infection is improving but not benefiting individuals unaware to be infected. To inform …
[PDF][PDF] Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
SJM Hahné, IK Veldhuijzen, L Wiessing, TA Lim… - 2013 - scienceopen.com
Background: Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV)
infection is improving but not benefiting individuals unaware to be infected. To inform …
infection is improving but not benefiting individuals unaware to be infected. To inform …
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
SJM Hahné, IK Veldhuijzen… - BMC infectious …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV)
infection is improving but not benefiting individuals unaware to be infected. To inform …
infection is improving but not benefiting individuals unaware to be infected. To inform …
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
SJM Hahnn, IK Veldhuijzen, L Wiessing… - BMC Infectious …, 2013 - go.gale.com
Background Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV)
infection is improving but not benefiting individuals unaware to be infected. To inform …
infection is improving but not benefiting individuals unaware to be infected. To inform …
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.
SJM Hahné, IK Veldhuijzen, L Wiessing… - 2013 - cabidigitallibrary.org
Background: Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV)
infection is improving but not benefiting individuals unaware to be infected. To inform …
infection is improving but not benefiting individuals unaware to be infected. To inform …
[HTML][HTML] Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
SJM Hahné, IK Veldhuijzen, L Wiessing… - BMC Infectious …, 2013 - ncbi.nlm.nih.gov
Background Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV)
infection is improving but not benefiting individuals unaware to be infected. To inform …
infection is improving but not benefiting individuals unaware to be infected. To inform …
[PDF][PDF] Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
SJM Hahné, IK Veldhuijzen, L Wiessing, TA Lim… - 2013 - researchgate.net
Background: Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV)
infection is improving but not benefiting individuals unaware to be infected. To inform …
infection is improving but not benefiting individuals unaware to be infected. To inform …
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.
SJM Hahné, IK Veldhuijzen, L Wiessing… - BMC Infectious …, 2013 - search.ebscohost.com
Background: Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV)
infection is improving but not benefiting individuals unaware to be infected. To inform …
infection is improving but not benefiting individuals unaware to be infected. To inform …
[HTML][HTML] Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
SJM Hahné, IK Veldhuijzen… - BMC Infectious …, 2013 - bmcinfectdis.biomedcentral.com
Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is
improving but not benefiting individuals unaware to be infected. To inform screening policies …
improving but not benefiting individuals unaware to be infected. To inform screening policies …